Previous Close | 16.94 |
Open | 0.00 |
Bid | 16.50 x 0 |
Ask | 16.67 x 0 |
Day's Range | 16.50 - 17.15 |
52 Week Range | 14.15 - 43.75 |
Volume | |
Avg. Volume | 172,915 |
Market Cap | 3.129B |
Beta (5Y Monthly) | 1.44 |
PE Ratio (TTM) | 18.52 |
EPS (TTM) | 0.90 |
Earnings Date | Mar 21, 2022 - Mar 25, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 52.04 |
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical dispensary in Auburndale, Florida. Located at 2003 US Hwy 92, the doors will open at 9 a.m. on Tuesday, August 16, 2022, with ongoing regular hours of 9 a.m. - 9 p.m. from Monday through Saturday and 10 a.m. - 8 p.m. on Sunday.
Owen Bennett of Jefferies cuts estimates on major cannabis names as the economic slowdown and oversupply in some markets bite into projections.
Trulieve CEO Kim Rivers sits down with Yahoo Finance Live to discuss the cannabis company's latest earnings report and outlook ahead of cannabis regulation bills.